L. V. Akulenko
Research Subjects
L. V. Akulenko has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Aleksander V. Polyakov
Research Centre for Medical Genetics, Moskvorechie Str., 1, 115522 Moscow, Russia
2 shared publications - Dmitry Yurievich Trofimov
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Akademika Oparina St., 4, 117997 Moscow, Russia
2 shared publications - E.A. Nersesyan
Russian University of Medicine
2 shared publications - F.V. Nenakhov
Central Clinical Hospital with Polyclinic of Administrative Directorate of the President of the Russian Federation
2 shared publications G.V. Mikhailovskaya
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
2 shared publications- I. I. Vityazeva
Endocrinology Research Centre
2 shared publications
Latest Publications
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 30 (5)
Heterogeneity of the molecular phenotype with uterine fibroids. Message II
The objective of study was expression profiles of 17 candidate genes in cells of morphologically verified myomatous nodes and unchanged myometrium in the associated and non-associated molecular phenotype of uterine fibroids with mutations in the MED12 gene. Material and methods. The research material was presented by 133 tissue samples obtained as a result of surgical treatment, of which 85 samples of myomatous nodes and 48 samples of morphologically unchanged myometrium. All samples of myomptous nodes were analyzed for the presence of somatic mutation MED12 by Sanger sequencing. Using reverse transcription and polymerase chain reaction (PCR) methods. The expression profile of 17 candidate genes (PAPPA1, GRPR, TYMS, PLAG1, VCAN, AVPR1A, ESR1, PLA2R1, RANKL, KLF11, KRT19, MMP11, ADAM12, MMP16, PCP4, SATB2, WIF1), presumably involved in the pathogenesis of uterine fibroids, selected based on bioinformatic analysis, was studied. For histological examination, sections with a thickness of 5 microns were obtained from paraffin blocks and stained with hematoxylin and eosin. An immunohistochemical study was performed to determine the surrogate molecular subtype of leiomyoma samples. Results and discussion. This report presents data indicating that for different molecular phenotypes of uterine fibroids associated and not associated with somatic mutations in the MED12 gene (MED12+ and MED12–, respectively), the expression profile of certain genes is significantly different. Hyperexpression of the HMGA2 gene is observed in some myomatous nodes with the molecular phenotype MED12–, and in some — decreased expression of the HMGA2 gene. The expression profile of other candidate genes in myomatous nodes of MED12– with increased/decreased expression of the HMGA2 gene also differs. In addition, according to immunohistochemical studies, hypervascularization and increased cellularity are detected in 39% of samples of myomatous nodes with the molecular phenotype MED12– and HMGA2+ more often than in samples of myomatous nodes with the molecular phenotype MED12– and HMGA2.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 30 (5)
Heterogeneity of the molecular phenotype with uterine fibroids. Message II
The objective of study was expression profiles of 17 candidate genes in cells of morphologically verified myomatous nodes and unchanged myometrium in the associated and non-associated molecular phenotype of uterine fibroids with mutations in the MED12 gene. Material and methods. The research material was presented by 133 tissue samples obtained as a result of surgical treatment, of which 85 samples of myomatous nodes and 48 samples of morphologically unchanged myometrium. All samples of myomptous nodes were analyzed for the presence of somatic mutation MED12 by Sanger sequencing. Using reverse transcription and polymerase chain reaction (PCR) methods. The expression profile of 17 candidate genes (PAPPA1, GRPR, TYMS, PLAG1, VCAN, AVPR1A, ESR1, PLA2R1, RANKL, KLF11, KRT19, MMP11, ADAM12, MMP16, PCP4, SATB2, WIF1), presumably involved in the pathogenesis of uterine fibroids, selected based on bioinformatic analysis, was studied. For histological examination, sections with a thickness of 5 microns were obtained from paraffin blocks and stained with hematoxylin and eosin. An immunohistochemical study was performed to determine the surrogate molecular subtype of leiomyoma samples. Results and discussion. This report presents data indicating that for different molecular phenotypes of uterine fibroids associated and not associated with somatic mutations in the MED12 gene (MED12+ and MED12–, respectively), the expression profile of certain genes is significantly different. Hyperexpression of the HMGA2 gene is observed in some myomatous nodes with the molecular phenotype MED12–, and in some — decreased expression of the HMGA2 gene. The expression profile of other candidate genes in myomatous nodes of MED12– with increased/decreased expression of the HMGA2 gene also differs. In addition, according to immunohistochemical studies, hypervascularization and increased cellularity are detected in 39% of samples of myomatous nodes with the molecular phenotype MED12– and HMGA2+ more often than in samples of myomatous nodes with the molecular phenotype MED12– and HMGA2.
- 1 January 2024
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 30 (4)
Heterogeneity of the molecular phenotype with uterine fibroids. Message I
- 1 January 2024
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 30 (4)
Heterogeneity of the molecular phenotype with uterine fibroids. Message I
- Open Access
- 30 November 2018
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 19 (3) , 60-69
Analysis of fertility potential in men with severe azoospermia and oligospermia of various etiology
The study objective is to evaluate the significance of the Y chromosome microdeletions for prediction of spermatozoa retrieval during testicle biopsy in men with severe azoospermia and oligozoospermia. Materials and methods . In total, 109 men aged 21 to 56 years (mean age 32.7 ± 0.2 years) with infertility in marriage were examined. Cytogenetic, special andrological, spermiological, and molecular genetic examinations were performed to evaluate non-genetic and genetic causes of infertility. Results . Normal karyotype and absence of AZF deletions were found in 75 men, presence of deletions – in 34. The frequencies of pathozoospermia forms were comparable in these groups. Spermatozoa were retrieved during biopsy in 47 (62.7 %) patients without Y chromosome microdeletions and only in 7 (20.6 %) patients with Y chromosome microdeletions. The men with AZF deletions were divided into 2 subgroups: men with complete AZF region deletions (n = 25) and men with partial AZF deletions (n = 9). Among men with complete deletions, azoospermia was diagnosed in 25 (100 %), spermatozoa were retrieved during biopsy in 2 (8 %); among men with partial deletions, azoospermia was diagnosed in 7 (77.8 %), severe oligozoospermia in 2 (22.2 %), spermatozoa were retrieved during biopsy in 5 (56 %). Then the patients were divided according to another criterion: 54 patients from whom spermatozoa were retrieved during biopsy and 55 men with negative results. Among patients with successful result of biopsy, Y chromosome microdeletions were identified in 7 (13 %); among patient with negative biopsy result – in 27 (49 %) (р < 0.01). Conclusion. Success rate of spermatozoa retrieval during testicle biopsy is significantly higher in men without AZF deletions (р < 0.01) than in men with deletions. Molecular genetic examination of Y chromosome microdeletions is recommended for men with azoospermia and severe oligozoospermia because it allows diagnosing of cause male infertility and predicting.
- 30 November 2018
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 19 (3) , 60-69
Open AccessAnalysis of fertility potential in men with severe azoospermia and oligospermia of various etiology
The study objective is to evaluate the significance of the Y chromosome microdeletions for prediction of spermatozoa retrieval during testicle biopsy in men with severe azoospermia and oligozoospermia. Materials and methods . In total, 109 men aged 21 to 56 years (mean age 32.7 ± 0.2 years) with infertility in marriage were examined. Cytogenetic, special andrological, spermiological, and molecular genetic examinations were performed to evaluate non-genetic and genetic causes of infertility. Results . Normal karyotype and absence of AZF deletions were found in 75 men, presence of deletions – in 34. The frequencies of pathozoospermia forms were comparable in these groups. Spermatozoa were retrieved during biopsy in 47 (62.7 %) patients without Y chromosome microdeletions and only in 7 (20.6 %) patients with Y chromosome microdeletions. The men with AZF deletions were divided into 2 subgroups: men with complete AZF region deletions (n = 25) and men with partial AZF deletions (n = 9). Among men with complete deletions, azoospermia was diagnosed in 25 (100 %), spermatozoa were retrieved during biopsy in 2 (8 %); among men with partial deletions, azoospermia was diagnosed in 7 (77.8 %), severe oligozoospermia in 2 (22.2 %), spermatozoa were retrieved during biopsy in 5 (56 %). Then the patients were divided according to another criterion: 54 patients from whom spermatozoa were retrieved during biopsy and 55 men with negative results. Among patients with successful result of biopsy, Y chromosome microdeletions were identified in 7 (13 %); among patient with negative biopsy result – in 27 (49 %) (р < 0.01). Conclusion. Success rate of spermatozoa retrieval during testicle biopsy is significantly higher in men without AZF deletions (р < 0.01) than in men with deletions. Molecular genetic examination of Y chromosome microdeletions is recommended for men with azoospermia and severe oligozoospermia because it allows diagnosing of cause male infertility and predicting.
- Open Access
- 14 August 2018
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 19 (2) , 40-51
GENETIC FACTORS OF MALE INFERTILITY, THEIR COMBINATIONS AND THE SPERMATOLOGICAL CHARACTERISTICS OF MEN WITH FERTILITY FAILURES
The objective is to study the occurrence of common genetic factors of male infertility in men with reproductive problems, their combinations and spermatological characteristics. Materials and methods . 393 men with infertility in marriage were examined. According to the results of the cytogenetic study, the sample is divided into 3 groups: 135 men with numerical sex chromosome abnormalities; 58 male patients with a balanced structural rearrangement; 200 men with normal karyotype. Y chromosome microdeletions, CFTR gene mutations and CAG-repeats polymorphism of AR gene were analyzed. Results . The Y-chromosome microdeletions partially AZFc deletions were detected in 13 % male patients with sex chromosome abnormalities. A combination of chromosomal abnormalities with AZF deletions and/or CFTR gene mutations and long CAG repeats of AR gene was found in 19 % infertile men with balanced chromosome rearrangements. Infertile men with normal male karyotype presented the frequency of common genetic factors of male infertility was almost 2 times higher than the combined frequency of these factors in groups of patients with chromosomes abnormalities. Azoospermia in men with normal karyotype and patients with chromosome abnormalities was diagnosed with the same frequency (58 %). In all men who have identified the presence of two or more genetic factors of male infertility, severe forms of pathozoospermia (azoospermia and severe oligozoospermia) were found. Conclusion . The combination of genetic factors of male infertility is accompanied by severe forms of pathozoospermia that indicates a possible additive effect of negative effect on spermatogenesis and male fertility.
- 14 August 2018
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 19 (2) , 40-51
Open AccessGENETIC FACTORS OF MALE INFERTILITY, THEIR COMBINATIONS AND THE SPERMATOLOGICAL CHARACTERISTICS OF MEN WITH FERTILITY FAILURES
The objective is to study the occurrence of common genetic factors of male infertility in men with reproductive problems, their combinations and spermatological characteristics. Materials and methods . 393 men with infertility in marriage were examined. According to the results of the cytogenetic study, the sample is divided into 3 groups: 135 men with numerical sex chromosome abnormalities; 58 male patients with a balanced structural rearrangement; 200 men with normal karyotype. Y chromosome microdeletions, CFTR gene mutations and CAG-repeats polymorphism of AR gene were analyzed. Results . The Y-chromosome microdeletions partially AZFc deletions were detected in 13 % male patients with sex chromosome abnormalities. A combination of chromosomal abnormalities with AZF deletions and/or CFTR gene mutations and long CAG repeats of AR gene was found in 19 % infertile men with balanced chromosome rearrangements. Infertile men with normal male karyotype presented the frequency of common genetic factors of male infertility was almost 2 times higher than the combined frequency of these factors in groups of patients with chromosomes abnormalities. Azoospermia in men with normal karyotype and patients with chromosome abnormalities was diagnosed with the same frequency (58 %). In all men who have identified the presence of two or more genetic factors of male infertility, severe forms of pathozoospermia (azoospermia and severe oligozoospermia) were found. Conclusion . The combination of genetic factors of male infertility is accompanied by severe forms of pathozoospermia that indicates a possible additive effect of negative effect on spermatogenesis and male fertility.